MOMETASONE/ OLOPATADINE NASAL SPRAY (Ryaltris ®)
Clinical Indication
Moderate to severe nasal symptoms associated with allergic rhinitis
Comments
Not yet reviewed
Date of classification
October 2021
Grey
Not yet reviewed drugs with no traffic light recommendation so not yet approved for use in LLR.
- New medicines, devices, appliances.
- New indication of existing medicine.
- New NICE TA which has not been reviewed.
- Not been requested for review by either TAS/LPT MMC.